Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apatinib Combined”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04517357
What this trial is testing

Trial of Fluzoparib Combined With Apatinib Versus Fluzoparib Monotherapy in Treatment With Relapsed Ovarian Cancer Patients

Who this might be right for
Relapsed Ovarian Cancer
Jiangsu HengRui Medicine Co., Ltd. 100
Not applicableUnknownNCT03066557
What this trial is testing

Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Jiangsu Cancer Institute & Hospital 80
Testing effectiveness (Phase 2)UnknownNCT04258644
What this trial is testing

Camrelizumab in Combination With Apatinib Mesylate, Paclitaxel-albumin and S-1 for Translational Treatment of Gastric Cancer

Who this might be right for
Gastric Cancer
Beijing Friendship Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06296563
What this trial is testing

Perioperative Treatment of Resectable Intrahepatic Cholangiocarcinoma With the Combination of Adebrelimab and Apatinib and HAIC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Lei ZHAO 20
Testing effectiveness (Phase 2)UnknownNCT03300765
What this trial is testing

Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid Cancer

Who this might be right for
Thyroid Cancer
Xiayun He, MD 20
Testing effectiveness (Phase 2)Study completedNCT05099848
What this trial is testing

A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute 21
Testing effectiveness (Phase 2)UnknownNCT04572542
What this trial is testing

Camrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric Cancer

Who this might be right for
Locally Advanced or Metastatic Gastric Adenocarcinoma
The First Affiliated Hospital of Xiamen University 46
Testing effectiveness (Phase 2)Looking for participantsNCT07770113
What this trial is testing

A Random, Non-controlled, Open Clinical Study of Apatinib Mesylate Combined With Albumin-bound Paclitaxel ± Adebrelimab in Treating Advanced Second-line Gastric Cancer

Who this might be right for
GC/GEJC
The First Affiliated Hospital of Zhengzhou University 50
Not applicableStudy completedNCT02998242
What this trial is testing

Apatinib in Combination With Stereotactic Body Radiation Therapy (SBRT) Treatment for Symptomatic Metastatic Prostate Cancer

Who this might be right for
Quality of Life
Sichuan Provincial People's Hospital 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06385873
What this trial is testing

RC48 Combined With Adebrelimab, Apatinib and S-1 as Neoadjuvant Therapy in Locally Advanced Gastric Cancer

Who this might be right for
Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 32
Early research (Phase 1)UnknownNCT02691871
What this trial is testing

Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR

Who this might be right for
Lung Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 20
Testing effectiveness (Phase 2)UnknownNCT04348032
What this trial is testing

Apatinib Combined With PLD vs PLD for Platinum-resistant Recurrent Ovarian Cancer

Who this might be right for
Platinum-resistant Recurrent Ovarian Cancer
Chinese Academy of Medical Sciences 152
Testing effectiveness (Phase 2)Looking for participantsNCT07294664
What this trial is testing

PDL1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer

Who this might be right for
Advanced Gastric CancerSHR1701
The First Affiliated Hospital of Zhengzhou University 78
Testing effectiveness (Phase 2)Study completedNCT02867956
What this trial is testing

Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer

Who this might be right for
Ovarian Cancer
Sun Yat-sen University 35
Testing effectiveness (Phase 2)UnknownNCT03701022
What this trial is testing

PD1 Combined With Apatinib in Patients With Relapsed or Refractory NK/T Cell Lymphoma

Who this might be right for
NK/T-cell Lymphoma
Peking University 61
Testing effectiveness (Phase 2)Looking for participantsNCT07135544
What this trial is testing

A Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerBiliary Tract Cancer (CCA)
Yongjun Chen 37
Testing effectiveness (Phase 2)UnknownNCT04128800
What this trial is testing

Appatinib Combined With S-1 in the Treatment of Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 20
Testing effectiveness (Phase 2)UnknownNCT05556200
What this trial is testing

A Phase II Trial of Camrelizumab in Combination With Apatinib for Neoadjuvant Treatment of Early-stage TNBC With a High Proportion of TILs

Who this might be right for
Breast CancerTriple-Negative Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 58
Testing effectiveness (Phase 2)UnknownNCT04590625
What this trial is testing

Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
Zhongshan Hospital Xiamen University 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT07687433
What this trial is testing

Long-Course Concurrent Chemoradiotherapy With Adebrelimab and Apatinib as Neoadjuvant Therapy for Locally Advanced/Low-Lying Rectal Cancer Requiring Sphincter Preservation

Who this might be right for
Rectal Cancer Patients
Harbin Medical University 43
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation